Drug Development

Article published on powerful tumor protein discovery method

Published in Cancer Weekly, October 15th, 2002

A new, rapid method of identifying proteins associated with cancer tumors could allow for the creation of cancer vaccines that help overcome the body's self-tolerance to certain cancers, according to an article in the September edition of The Journal of Immunology.

The new method, SPHERE (Solid Phase Epitope Recovery), is being used extensively by Genzyme Molecular Oncology (GZMO).

The article, "Solid-Phase Epitope Recovery: A High Throughput Method for Antigen Identification and Epitope Optimization," is authored by Charles A. Nicolette, PhD, leader of Genzyme Molecular Oncology's antigen discovery team, and a group of his colleagues. The...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2002-10-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry